Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $20.8000 (-2.94%) ($20.4600 - $22.0600) on Tue. Feb. 25, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.88% (three month average) | RSI | 70 | Latest Price | $20.8000(-2.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.3% a day on average for past five trading days. | Weekly Trend | HALO advances 3.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(54%) IWO(54%) IWM(50%) IWC(49%) XBI(49%) | Factors Impacting HALO price | HALO will decline at least -0.94% in a week (0% probabilities). VIXM(-38%) VXX(-19%) UUP(-7%) TLT(-3%) SHY(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.94% (StdDev 1.88%) | Hourly BBV | 0 () | Intraday Trend | -2% | | | |
|
5 Day Moving Average | $21.34(-2.53%) | 10 Day Moving Average | $20.93(-0.62%) | 20 Day Moving Average | $20.27(2.61%) | To recent high | -4.7% | To recent low | 17.3% | Market Cap | $2.843b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |